Transcriptome Analysis to Identify Human Spermatogonial Cells from Sertoli Cell Only Testes.
To determine whether gene products from spermatogenic cells can be detected in Sertoli cell only (SCO) testes, transcriptome analysis using next-generation sequencing (NGS) was performed using human testicular samples. This study enrolled twenty men with nonobstructive azoospermia whose histological diagnosis was SCO and who had no germ cells in an IVF analysis and 5 men with obstructive azoospermia (OA) and histologically normal spermatogenesis. Individual differences in the transcriptomes of OA testicular tissues generated on the Illumina platform were compared as fragments per kilobase of exon per million mapped sequence reads (FPKM). mRNA expression and the localization of targeted gene products were confirmed by quantitative RT-PCR and immunohistochemical analyses, respectively. From the 23,003 genes screened using NGS, a total of 5,666 genes were analysed. As representative markers of immature germ cells, UTF1, CD9, DDX4, EPCAM, GFRA1, KIT, LIN28, DMRT, GPR125, UCHL1, and NANOG transcripts were detected in 13 (65%) SCO samples. RT-PCR showed significant mRNA expression of UTF1, CD9, DDX4, and KIT in SCO samples. Immunostaining showed the localization of DDX4-positive cells, presumably spermatogonia, in 9 (45%) of the SCO samples, whereas these cells lacked proliferative cell nuclear antigen expression. A number of SCO testes contain immature germ cells (spermatogonia, spermatogenic stem cells) with a variety of gene expression profiles. SCO is a heterogeneous pathophysiology that may be correctable by medical treatment or regenerative technologies.